MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$17,496K
EPS
-$0.65
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Research and development
12,034
12,340
12,042
67,197*
General and administrative
7,337
7,195
7,223
9,540*
Total operating expenses
19,371
19,535
19,265
76,737
Loss from operations
-19,371
-19,535
-19,265
-76,737*
Other income, net
1,791
1,892
2,100
2,168*
Net loss
-17,580
-17,643
-17,165
-74,569*
Unrealized gain on marketable securities
84
-19
-15
-515*
Total comprehensive loss
-17,496
-17,662
-17,180
-75,084
Basic EPS
-0.65
-0.65
-0.08
-1.762
Diluted EPS
-0.65
-0.65
-0.08
-1.762
Basic Average Shares
26,963,107
26,949,752
215,410,253
42,618,810
Diluted Average Shares
26,963,107
26,949,752
215,410,253
42,618,810
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Total comprehensive
loss
-$17,496K
(4.28%↑ Y/Y)
Unrealized gain on
marketable securities
$84K
(-45.45%↓ Y/Y)
Net loss
-$17,580K
(4.62%↑ Y/Y)
Other income, net
$1,791K
(32.08%↑ Y/Y)
Loss from operations
-$19,371K
(2.11%↑ Y/Y)
Total operating
expenses
$19,371K
(-2.11%↓ Y/Y)
Research and development
$12,034K
(-9.79%↓ Y/Y)
General and
administrative
$7,337K
(13.79%↑ Y/Y)
Buy us a coffee
RAPT Therapeutics, Inc. (RAPT)
RAPT Therapeutics, Inc. (RAPT)